Mark Wade
Johnson & Johnson (United States)(US)
Publications by Year
Research Areas
Phagocytosis and Immune Regulation, Cancer Mechanisms and Therapy, Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization(1997)152 cited
- → Evaluation of a 7-Day Continuous Intravenous Infusion of Decitabine: Inhibition of Promoter-Specific and Global Genomic DNA Methylation(2005)140 cited
- → Design, Synthesis, and Biological Evaluation of a Series of Novel AXL Kinase Inhibitors(2011)89 cited
- → Novel Antioxidants Zolimid and AEOL11201 Ameliorate Colitis in Rats(2001)86 cited
- → A phase I/II study of decitabine in combination with panitumumab in patients with wild-type (wt) KRAS metastatic colorectal cancer(2013)66 cited
- → A Phase III study of radiation therapy (RT) and O6-benzylguanine + BCNU versus RT and BCNU alone and methylation status in newly diagnosed glioblastoma and gliosarcoma: Southwest Oncology Group (SWOG) study S0001(2014)62 cited
- → Single-Cell Proteomic Profiling Identifies Combined AXL and JAK1 Inhibition as a Novel Therapeutic Strategy for Lung Cancer(2020)62 cited
- → Use of Oral N -Acetylcysteine for Protection of Melanocytic Nevi against UV-Induced Oxidative Stress: Towards a Novel Paradigm for Melanoma Chemoprevention(2009)45 cited
- → Nitric Oxide Modulates the Activity of the Hemoproteins Prostaglandin I2Synthase and Thromboxane A2Synthase(1997)42 cited
- → Conditional Expression of 15-Lipoxygenase-1 Inhibits the Selenoenzyme Thioredoxin Reductase(2004)38 cited